← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

NDA · New Drug Application · Sponsor: LONG GROVE PHARMS · Approved 2024-07-11

Drug application

FDA Application #

NDA217766

Application type

New Drug Application

Brand name

VASOPRESSIN IN SODIUM CHLORIDE 0.9%

Generic name

VASOPRESSIN

Active ingredients

VASOPRESSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

LONG GROVE PHARMS

Manufacturer

Long Grove Pharmaceuticals, LLC

First approval

2024-07-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown